Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-27

Clinical Trial Update: Efficacy and Safety of Flamboyant 125/12 Association in the Treatment of Adults With Moderate Asthma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the efficacy and safety of Flamboyant 125/12 in adults with moderate asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flamboyant 125/12

Snippet

Sponsor: EMS | Conditions: Asthma | Phase 3 | Status: UNKNOWN